Pharmaceutical Quality Management Software Market worth $2.98 billion by 2030
The report "Pharmaceutical Quality Management Software (QMS) Market by Process (Clinical Trial, Regulatory, Manufacturing, Commercialization), Application (eSOP, CAPA, Compliance), Size (Large, Small), End User (pharma, biotech, CRO), Region - Global Forecast to 2030", is projected to reach USD 2.98 billion by 2030 from USD 1.59 billion in 2025, at a high CAGR of 13.3% during the forecast period.
Browse 80 market data Tables and 50 Figures spread through 250 Pages and in-depth TOC on "Pharmaceutical Quality Management Software (QMS) Market by Process (Clinical Trial, Regulatory, Manufacturing, Commercialization), Application (eSOP, CAPA, Compliance), Size (Large, Small), End User (pharma, biotech, CRO), Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-quality-management-software-market-79122728.html
The pharmaceutical quality management software market is advancing rapidly. The companies are increasingly focusing on end-to-end product lifecycle management, ensuring quality from R&D through manufacturing to post-market surveillance. The globalization of pharmaceutical manufacturing has created a need for standardized digital quality systems across multiple sites, while automation in workflows such as CAPA, audits, and change management reduces errors and accelerates processes. Additionally, advanced analytics support data-driven decision-making, and stricter regulatory scrutiny in emerging markets is driving adoption. The shift toward paperless operations, coupled with an emphasis on patient safety and maintaining public trust, further reinforces the importance of quality management software as a critical tool for ensuring consistent quality and compliance.
“The large enterprise segment accounted for the largest share of the pharmaceutical quality management software market in 2024, by enterprise size”
By enterprise size, large enterprises hold the largest share of the pharmaceutical quality management software market. This dominance is attributed to their extensive production volumes, complex operational structures, and stringent regulatory compliance requirements. Large pharmaceutical companies have the financial capability and technological infrastructure to implement comprehensive QMS solutions that integrate multiple quality processes across global facilities. These enterprises prioritize robust quality management systems to ensure product consistency, enhance traceability, and minimize the risk of non-compliance. Moreover, their focus on digital transformation, automation, and data-driven decision-making further drives the adoption of advanced QMS platforms within this segment..
“The pharmaceutical companies accounted for the largest share of the pharmaceutical quality management software market in 2024, by end user”
By end user, pharmaceutical companies hold the largest share of the pharmaceutical quality management software market. This dominance is primarily due to the critical need for maintaining stringent quality standards throughout drug development, manufacturing, and distribution processes. Pharmaceutical companies face rigorous regulatory requirements from agencies such as the FDA and EMA, driving the adoption of advanced QMS solutions to ensure compliance, traceability, and product consistency. These systems help streamline quality processes, manage documentation, track deviations, and support continuous improvement initiatives.
“North America dominated the pharmaceutical quality management software market in 2024”
In 2024, North America reinforced its position as a global leader in the pharmaceutical quality management software market. The region is characterized by a highly regulated pharmaceutical sector and the presence of complex, frequently updated FDA guidelines that necessitate rigorous compliance. Significant investments in digital transformation across pharmaceutical manufacturing and development further reinforce this position. The emphasis on product safety, risk mitigation, and standardized operational processes drives demand for integrated quality management software solutions that facilitate documentation management, streamline audits, automate corrective and preventive actions (CAPA), and oversee process deviations. Leading pharmaceutical companies in the US and Canada have increasingly adopted cloud-based platforms, AI-enabled analytics, and centralized quality oversight to address the growing complexity of clinical trials, supply chain networks, and decentralized manufacturing operations. Supported by a strong presence of global pharmaceutical leaders, advanced healthcare infrastructure, and sustained R&D investment.
Key Players
The key players functioning in the Pharmaceutical quality management software market include Veeva Systems Inc. (US), MasterControl Solutions, Inc. (US), Honeywell International Inc. (US), IQVIA (US), Qualio, Inc. (US), Hexagon AB (Sweden), AssurX, Inc. (US), QT9 Software (US), Dassault Systèmes (France), ComplianceQuest (US), Ideagen (UK), SoftExpert (Brazil), Instem (UK), Intelex Technologies (Canada), Intellect, Inc. (US), AmpleLogic (India).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Quality Management Software (QMS) Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
